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Staphylococcus aureus strains lacking agr- and sarA-dependent gene products or specific MSCRAMM (mi-
crobial surface components recognizing adhesive matrix molecules) adhesins were compared for the ability to
activate inflammatory responses in the lung. The mutants were evaluated for virulence in a mouse model of
pneumonia and by quantifying their ability to stimulate interleukin-8 (IL-8) and granulocyte-macrophage
colony-stimulating factor (GM-CSF) expression in respiratory epithelial cells. In a neonatal mouse, only
strains with intact agr and sarA loci were consistently associated with invasive, fatal pulmonary infection (P <
0.001) and sarA was specifically required to cause bacteremia (P < 0.001). The agr and/or sarA mutants were,
nonetheless, fully capable of producing pneumonia and were as proficient as the wild-type strain in stimulating
epithelial IL-8 expression, a polymorphonuclear leukocyte chemokine, in airway cells. In contrast, agr and
especially sarA mutants induced less epithelial GM-CSF expression, and MSCRAMM mutants lacking fi-
bronectin binding proteins or clumping factor A, a ligand for fibrinogen, were unable to stimulate epithelial
GM-CSF production. The ability to induce IL-8 expression was independent of the adherence properties of
intact bacteria, indicating that shed and/or secreted bacterial components activate epithelial responses. While
conserved staphylococcal components such as peptidoglycan are sufficient to evoke inflammation and cause
pneumonia, the agr and sarA loci of S. aureus are critical for the coordination of invasive infection of the lungs.
Staphylococcus aureus, a major cause of pulmonary infec-
tion, is associated with primary pneumonia in infants and
young children and secondary pneumonia following viral in-
fection and is one of the most common causes of hospital-
acquired pneumonia (National Nosocomial Infection Surveil-
lance Data, www.cdc.gov, 1999). S. aureus frequently
contributes to airway disease in patients with cystic fibrosis,
infecting 50% of patients by age 10 (Cystic Fibrosis Founda-
tion Patient Registry Data, Annual Report 2000). Despite its
association with pulmonary disease, most of the data used to
explain the pathogenesis of S. aureus infection is derived from
studies of infection involving skin and soft-tissue structures,
endothelial surfaces, and professional immune cells. The ex-
pression of specific adhesins, fibronectin binding proteins (12),
fibrinogen binding proteins, or MSCRAMMs (microbial sur-
face components recognizing adhesive matrix molecules) (15)
is important in these infections. Secreted S. aureus exoprod-
ucts, the hemolysins, coagulase, and exotoxins are associated
with both local and hematogenous infections. S. aureus also
evokes host inflammatory responses through the activation of
chemokine and cytokine expression and the recruitment of
polymorphonuclear leukocytes (PMNs) to the site of infection
(24, 26, 31, 34).
The expression of many of these S. aureus virulence factors
is regulated by the agr locus, a complex global regulator (7).
The agr locus controls expression of RNAs II and III and is
responsible for negative regulation of the synthesis of cell
surface proteins, including protein A and coagulase, and pos-
itive regulation of the expression exoproducts such as the he-
molysins and toxic shock syndrome toxin 1. The sarA locus,
which includes three overlapping transcripts, all encoding the
14.5-kDa SarA protein (6), is important in the activation of
several virulence genes, including those that encode the hemo-
lysins and fibronectin binding proteins (33). Mutants that lack
agr sarA function are less virulent in animal models of endoph-
thalmitis (2) and endocarditis (4). However, the complex in-
teractions of these loci make it difficult to predict the in vivo
response to mutations in these global regulators.
Since S. aureus is a major respiratory pathogen, we were
interested in establishing if the agr and sarA loci, which have
been shown to be important in the pathogenesis of staphylo-
coccal infection at other sites, are also critical for the estab-
lishment of infection in the respiratory tract. Using a neonatal-
mouse model of respiratory tract infection, as well as a number
of in vitro assays of chemokine and cytokine expression, we
found that mutations affecting the global regulatory loci agr
and sarA significantly impair the ability of the organisms to
cause invasive infection. However, all of the staphylococcal
strains examined retained the ability to induce proinflamma-
tory responses in airway epithelial cells both in vitro and in
vivo.
MATERIALS AND METHODS
Bacterial strains. S. aureus RN6390 is a wild-type strain that, along with the
mutants listed, has been previously characterized in detail (2, 4) (Table 1).
RN6911 (agr) is a mutant of RN6390 with a agr::tetM insertion, ALC136 (sarA)
is RN6390 with an sarA::Tn917LTV1 insertion, and ALC135 is RN6390 with both
a agr::tetM insertion and an sarA::Tn917LTV1 insertion. ALC1645 (spA) is a
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protein A mutant of RN6390 (3). S. aureus Newman is a wild-type strain.
Mutants of strain Newman include ALC60 (clfA), which lacks clumping factor, a
major fibrinogen binding protein (32), and DU5886 (fnbpA fnbpB), which lacks
fibronectin binding proteins A and B. CYGP medium was used for all of the S.
aureus strains (20). Chemicals were obtained from Sigma Chemical Co., St.
Louis, Mo., unless otherwise specified.
Cell culture. 1HAEo, a simian virus 40-transformed human airway cell line
obtained from D. Gruennert, University of Vermont, Burlington (8), was grown
in Dulbecco’s modified essential minimal medium (DMEM)-F12, and 16HBE
cells, simian virus 40-transformed human bronchial epithelial cells, were grown
in minimal essential medium (MEM) with 10% fetal bovine serum as described
previously (23). 9HTEo, a human tracheal epithelial cell line, was obtained
from P. Davis (Case Western Reserve University, Cleveland, Ohio) and grown in
DMEM-F12 with fetal bovine serum (23). All of the cell culture media used
included penicillin, streptomycin, L-glutamate, and amphotericin B.
Bacterial adherence assays. 1HAEo cells were grown in 96-well plates until
confluent as previously described (8). S. aureus strains grown overnight on CYGP
plates were resuspended in phosphate-buffered saline (PBS) and labeled with
[35S]methionine for 1 h at 37°C, washed, and resuspended in DMEM-F12 with
0.1% fetal calf serum at a concentration of 108 CFU/ml. Following a 60-min
incubation with the epithelial cells and three PBS washes, monolayers were
solubilized with 0.2% NaOH and scintillations were counted. Statistical analysis
was performed by analysis of variance (Microsoft Excel 5.0).
Isolation of S. aureus peptidoglycan. Peptidoglycan was isolated from 1-liter
cultures of RN6390 and RN6911 by standard methods (10). The final material
isolated was lyophilized and resuspended in PBS and used at a concentration of
50 g/ml.
S. aureus induction of IL-8, G-CSF, and GM-CSF expression. Confluent
monolayers of 16HBE human bronchial epithelial cells grown in 10-cm dishes
were incubated for 60 min with 5 108 CFU of S. aureus RN6390 or RN6911 per
ml. The epithelial cells were washed and lysed with RLT buffer in accordance
with the RNeasy Mini Kit protocol (Qiagen, Valencia, Calif.). Lysate was ho-
mogenized with a Qiashredder, and total RNA was isolated with an RNeasy Mini
Kit. Reverse transcription was performed with Omniscript Reverse Transcriptase
(RT) from Qiagen and oligo(dT) from Perkin-Elmer (Boston, Mass.). PCR was
done with Taq from Roche Biochemicals (Indianapolis, Ind.). The PCR primers
used for human granulocyte colony-stimulating factor (G-CSF) were 5-GCTT
AGAGCAAGTGAGGAAG and 5-AGGTGGCGTAGAACGCGGTA, those
used for granulocyte-macrophage colony-stimulating factor (GM-CSF) were 5-
GGAGCATGTGAATGC CATC and 5-ATCTGGGTTGCACAGGAAG,
those used for IL-8 were 5-TACTCCAAACCTTTCCAACCC and 5-AACTT
CTCCACAACCCTCTG, and those used for -actin were 5-GTGGGCCGCT
CTAGGCACCA and 5-GGTTGGCCTTAGGGTTCAGGGGGG.
IL-8 and GM-CSF ELISAs. IL-8 and GM-CSF in 1HAEo or 16HBE cell
culture supernatants were detected by enzyme-linked immunosorbent assay
(ELISA) using monoclonal anti-IL-8 immunoglobulin G (R&D, Minneapolis,
Minn.) as previously described (8) and the GM-CSF Quantikine kit (R&D).
1HAEo cells were grown in DMEM-F12 medium, and 16HBE cells were
grown in MEM. Confluent monolayers in 96-well plates were weaned from
serum for 24 h and then incubated for 60 min with either PBS, standardized
inocula of the S. aureus strains listed above (5  108 CFU/ml), S. aureus lipo-
teichoic acid (10 to 100 g/ml), peptidoglycan isolated from RN6390 and
RN6911 (50 to 250 g), or IL-1 (120 ng/ml) (CalBiochemical Corp., San Diego,
Calif.), which was used as a positive control. The wells were washed and sterilized
by the addition of 100 g of gentamicin per ml, supernatants were harvested 18 h
later, and IL-8 or GM-CSF was measured by ELISA. Control wells were stained
with trypan blue to verify cellular viability of 75%. Quintuplicate wells were
inoculated, and the mean and standard deviation were calculated. The data were
tested for statistically significant variance with GraphPad InStat software by a
one-way analysis of variance with Bonferroni’s post test to test the null hypoth-
esis that there was no difference in the amount of the outcome variable (IL-8 or
GM-CSF production) compared with that of the control strain. Each experiment
was performed on at least two separate occasions, and a representative experi-
ment was selected.
Mouse model of infection. BALBc/ByJ mice (10 to 14 days of age; mean
weight, 5.96 	 2.1 g) were intranasally inoculated with an inoculum of 2  108
CFU of S. aureus in 10 l as previously described (28) and returned to their
mothers. Mice were sacrificed 24 h later by using Avertin (2,2,2-tribromoethanol;
Aldrich, Milwaukee, Wis.). The left lung and the spleen were homogenized in
100 l of PBS and cultured on CYGP plates. Colonies were tested for the
expected antibiotic resistance markers. The right lung was fixed in formalin for
routine histopathological studies. Pneumonia was defined as the recovery of
102 CFU of S. aureus per 100 l of minced lung tissue, as well as histopathology
indicative of acute bacterial pneumonia (PMN infiltration, hemorrhage, and
edema). Bacteremia was defined as recovery of any staphylococci from the
spleen. Animals found dead were treated similarly. All procedures were done in
accordance with institutional animal care guidelines. Differences in the rates of
pneumonia, bacteremia, and mortality at 24 h between the control group infected
with RN6390 and the mutant strains were analyzed for statistical significance by
chi-square analysis.
Histopathology and immunocytochemistry. Snap-frozen sections of formalin-
fixed mouse lungs were cryosectioned onto poly-L-lysine-coated slides and dried
at room temperature. Sections were incubated with 10 g of goat anti-mouse
GM-CSF antibody per ml and subsequently with a secondary antibody. Sections
were then treated with Vectastain (Vector Labs, Burlingame, Calif.) ABS re-
agent, peroxidase substrate, and hematoxylin counterstain and mounted with
Vectamount.
RESULTS
The agr locus is associated with virulence. The virulence of
S. aureus strains was tested in neonatal BALBc/ByJ mice fol-
lowing intranasal inoculation with either wild-type S. aureus
RN6390 or a mutant strain. Since expression of agr- and sarA-
dependent virulence factors is contingent upon cell density and
growth phase (7, 22), the mutants were first compared to as-
certain that, at least under laboratory conditions, their growth
rates did not differ significantly (data not shown). At 18 h
following inoculation, wild-type strain RN6390 was the most
virulent, causing pneumonia and bacteremia in 100% of the
mice inoculated and 30% mortality (Fig. 1). agr mutant strain
RN6911 was less virulent than the parental strain; only 41% of
the mice were bacteremic (P 
 0.01 compared with RN6390),
and RN6911 caused no deaths (P 
 0.001). The mutants lack-
ing sarA expression, with either a single mutation (ALC136) or
the agr sarA double mutation (ALC135), respectively, caused
bacteremia in 16 and 17% of the mice inoculated (P 
 0.001
for each compared with RN6390). Only a single death was
associated with ALC135 infection, and none was associated
with ALC136, indicating the importance of the sarA locus in
overall virulence.
While agr and sarA were important in overall virulence,
TABLE 1. Bacterial strains used in this study
Strain Description Reference(s)
RN6390 Parental strain 2, 33
RN6911 agr mutant of RN6390 with a agr::tetM insertion 2, 33
ALC136 RN6390 with an sarA::Tn917LTV1 insertion 2, 33
ALC135 agr sarA mutant of RN 6390 with both a agr::tetM and an sarA::Tn917LTV1 insertion 2, 33
ALC1645 RN6390 spA (protein A) mutant 3
Newman Wild type 32
ALC60 Strain Newman clfA (clumping factor) mutant 21
DU5886 Strain Newman fnbpA fnbpB (fibronectin binding proteins A and B) mutant 33
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neither locus was essential for the induction of airway inflam-
mation. Infection with an agr, sarA, or agr sarA mutant was
associated with pneumonia in 71, 48, and 75%, of the mice,
respectively, as defined by recovery of the organisms from the
lungs (Fig. 1) and confirmed by histopathology (Fig. 2). Com-
pared with the normal, uninfected lungs, a significant cellular
inflammatory response was evident in those of all infected
mice, with infiltration of PMNs. Edema of the tissues and
cellular infiltration and consolidation were prominent. The S.
aureus mutants caused significant inflammation, even though
many animals did not appear ill, nor were they necessarily
bacteremic.
Staphylococcal stimulation of epithelial cytokine and che-
mokine expression. Bacterial interactions with airway epithe-
lial cells induce the expression of proinflammatory chemokines
such as IL-8 and the cytokines GM-CSF and G-CSF. These
cytokines serve to recruit, activate, and inhibit PMN apoptosis
(1, 17), as demonstrated in vitro and in animal studies of airway
infection (18). Having found that wild-type and agr mutant
strains elicit a PMN response in murine airways, we compared
the abilities of the mutants to activate expression of these
proinflammatory chemokines and cytokines in human airway
cell lines (Fig. 3). Expression of G-CSF, GM-CSF, and IL-8
was assessed by RT-PCR. Following a 60-min incubation with
equivalent inocula of RN6390 and RN6911, there was appar-
ent induction of both cytokines and IL-8.
Stimulation of IL-8 expression by staphylococci and staph-
ylococcal components. IL-8 is a major PMN chemokine ex-
pressed by human airway epithelial cells in response to bacte-
rial infection. The amount of IL-8 produced by 1HAEo
epithelial monolayers following stimulation with S. aureus mu-
tants was quantified by ELISA (Fig. 4A). For each of the
strains tested, there was a linear IL-8 dose response for the 106
to 108 CFU/ml applied (data not shown). At the single con-
centration shown, there were no statistically significant differ-
ences in the amount of IL-8 production elicited by the agr
mutant and parental strain RN6390. Both of the strains with
sarA mutations elicited less IL-8 than did the wild type (P 

0.001 for both ALC135 and ALC136), although the amount of
FIG. 1. Virulence of S. aureus strains in a neonatal-mouse model of
infection. Numbers of mice used: RN6390, 30; RN6911, 31; ALC136,
32; ALC135, 46. The percentage of the total number of mice inocu-
lated with each strain that developed pneumonia or bacteremia or died
at 18 h following infection is indicated on the y axis. Black bars, %
pneumonia; open bars, % bacteremia; shaded bars, % mortality.
FIG. 2. Histology of S. aureus infection in the murine lung. Control, BALBc/ByJ mouse inoculated with PBS. RN6390, wild type (note edema,
PMN infiltration, and loss of air spaces). ALC135, agr sarA mutant. RN6911, agr mutant. ALC136, sarA mutant (PMN infiltration and edema are
similar to those associated with infection due to the wild-type strain). Magnification, 250.
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IL-8 expression induced by these sarA mutants was, nonethe-
less, within a range that is biologically significant. The protein
A mutant (ALC1645) was fully capable of inducing IL-8 ex-
pression. S. aureus strain Newman and the isogenic mutant
lacking fibronectin binding proteins A and B were equivalent
in the ability to stimulate IL-8 production. ALC60, a clfA
mutant lacking clumping factor, the major fibrinogen binding
protein, stimulated 30% less IL-8 than did the parental strain
(P 
 0.001) (Fig. 4B). Staphylococcal lipoteichoic acid at con-
centrations ranging from 10 to 100 g/ml did not elicit an IL-8
response (only one concentration shown), whereas S. aureus
peptidoglycan from RN6390 (or RN6911 [data not shown])
stimulated equivalent amounts of IL-8 (Fig. 4C).
GM-CSF expression is differentially induced by S. aureus
mutants. The proinflammatory cytokine GM-CSF is also ex-
pressed by epithelial cells in response to bacterial infection and
has a major effect in preventing the constitutive apoptosis of
activated PMNs (29). Staphylococcal mutants were tested for
the ability to activate epithelial GM-CSF expression and to
establish if the same staphylococcal ligands activate expression
of IL-8 and GM-CSF, which are both dependent upon NF-B
for expression (Fig. 5). In contrast to the results obtained with
IL-8, agr-dependent gene products were required to induce
GM-CSF production. Both the agr and agr sarA mutants stim-
ulated approximately 30% less GM-CSF than did the parental
strain (P 
 0.001 for each), and the agr sarA mutant stimulated
61% less (P 
 0.001). A protein A mutant was also less effec-
tive in its activation of GM-CSF expression, stimulating a re-
sponse equal to 31% of that of the parental strain (P 
 0.001).
S. aureus strain Newman stimulated slightly less GM-CSF pro-
duction than did RN6390, and mutants lacking expression of
the MSCRAMM ligands responsible for fibronectin binding
and fibrinogen binding were unable to activate GM-CSF pro-
duction (P 
 0.001). There were no significant differences in
the induction of G-CSF expression by the wild-type and mu-
tant strains (data not shown).
GM-CSF expression in the murine lung. To document that
GM-CSF is expressed in vivo in response to pulmonary S.
aureus infection, sections of mouse lung were screened for
GM-CSF 24 h following inoculation with the S. aureus strains
(Fig. 6). There was prominent expression of GM-CSF in the
cells lining the large airways, stimulated with either the wild-
type or the agr mutant S. aureus strain, and much less GM-CSF
production was associated with the cells lining the smaller
airways.
S. aureus adherence does not correlate with virulence. For
many pathogens, virulence can be correlated directly with tis-
sue binding, as has been demonstrated for S. aureus soft-tissue
infections. The abilities of agr, sarA, and agr sarA mutant and
wild-type strains of S. aureus to bind to respiratory epithelial
FIG. 3. Induction of chemokine and cytokine expression by S. au-
reus. G-CSF, GM-CSF, and IL-8 expression in airway epithelial cells
was assessed by RT-PCR in unstimulated control cells or following 60
min of incubation with 5  108 CFU of S. aureus RN6390 or RN6911
per ml.
FIG. 4. IL-8 expression in airway epithelial cells. Equivalent inoc-
ula of the S. aureus strains listed (5  108 CFU/ml), IL-1 (120 ng/ml),
peptidoglycan isolated from strain RN6390 (50 g/ml), and lipotei-
choic acid (50 g/ml) were incubated with 1HAEo (A and B) or
16HBE (C) cells for 60 min. The monolayers were sterilized with
gentamicin and refed. Cell culture supernatants were harvested 18 h
later, and IL-8 content was determined by ELISA and expressed as
nanograms per milligram of protein. Each experimental point was
determined in quintuplicate, and a mean and standard error were
generated and subjected to analysis of variance. Each experiment was
repeated at least twice, and representative results are shown.
130 HEYER ET AL. INFECT. IMMUN.
cells were quantified (Fig. 7). Approximately 3.9% of the in-
oculum of parental strain RN6390 was adherent, almost three-
fold more than that of agr mutant RN6911 (P 
 0.001). The
sarA mutant ALC136 bound slightly more than the wild-type
strain (consistent with the negative effect of sarA on surface
protein expression). The agr sarA double mutant ALC135
bound much less than did the wild-type strain (P 
 0.001) and
slightly less than the agr mutant, with less than 1% of the
inoculum adherent. Binding was dependent upon the presence
of a small amount of serum (0.1%) and did not correlate with
the ability to cause pneumonia in the murine lung.
DISCUSSION
In the studies detailed in this report, the interactions of S.
aureus and airway epithelial cells were examined to determine
the contributions of the agr and sarA loci to the pathogenesis of
pulmonary infection. As expected, these global regulatory loci
were important for coordination of the expression of the many
gene products required for invasive infection. In contrast, the
ability to elicit PMN-dominated airway inflammation was a
fundamental property of all of the S. aureus strains studied and
was not dependent upon the agr locus. Much of the initial
inflammatory response to inhaled bacteria is signaled by the
mucosal cells lining the respiratory tract. S. aureus has the
potential to activate host cytokine and chemokine responses by
the direct effects of cellular components such as peptidoglycan,
lipoteichoic acid, or other adhesins on the mucosal epithelium
(27). agr staphylococci activate IL-8 expression by airway cells
through the ligation of asialo-GM1 receptors, stimulation of
Ca2 fluxes, mitogen-activated protein kinase phosphoryla-
tion, and activation of NF-B (24). As shown in this report, agr
mutant organisms can also activate IL-8, as well as GM-CSF,
expression, indicating that several S. aureus gene products are
likely to be involved in this host-bacterium interaction.
S. aureus has the potential to interact with mucosal cells in
several different ways; through superficial interactions of shed
bacterial products such as protein A or peptidoglycan and
epithelial receptors, by adherence of intact bacteria to host
epithelial cells, or by invasion and internalization of the bac-
teria (9, 25). Several reports have documented S. aureus stim-
ulation of endothelial cytokine responses (26, 31, 35) and have
identified genes that are activated by the internalization of
these bacteria by different cell types (9). The in vitro studies
detailed, with brief exposure of the airway cells to the bacteria,
are likely to reflect superficial interactions between the organ-
isms and the epithelium. The ability of S. aureus to adhere to
airway epithelial cells did not directly correlate with induction
of IL-8 expression or with the ability to induce pneumonia in
mice. The agr mutants had less than 25% of the binding capa-
bility of either the wild-type or the sarA mutant strain but
virtually the same ability to induce IL-8 expression. This is
consistent with the hypothesis that loosely bound or shed com-
ponents such as peptidoglycan or protein A are immunostimu-
latory and neither attachment of intact organisms nor frank
FIG. 5. GM-CSF expression in airway epithelial cells following ex-
posure to S. aureus. 1HAEo cell culture supernatants harvested 18 h
following a 60-min incubation with a 5  108-CFU/ml inoculum of
each strain listed were screened for GM-CSF content by ELISA. The
cells were weaned to 0.1% fetal calf serum for 24 h prior to inocula-
tion, and duplicate wells were stained with trypan blue to assess via-
bility. Each experimental point was determined in quintuplicate, and a
mean and standard error were generated and subjected to analysis of
variance.
FIG. 6. Immunohistological detection of GM-CSF expression by
the airway epithelial cells lining the large murine bronchi. Frozen
sections of murine lung were examined for GM-CSF expression 18 h
following intranasal administration of RN6390. A representative sec-
tion is shown demonstrating immunoreactive material in the cells lin-
ing the large airways. Original magnification, 250.
FIG. 7. Adherence properties of S. aureus strains. The relative ad-
herence of 35S-labeled organisms to 1HAEo airway epithelial cell
monolayers was measured. The percentage of the added inoculum
(5  108 CFU/ml) that bound is indicated.
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invasion of the epithelial cell is required to activate airway
cytokine and chemokine responses. This differs from other
models of S. aureus infection in which the expression of a
specific adhesin, such as fibronectin binding protein (25), for
example, is required to initiate disease. Instead, induction of
airway inflammation can be mediated by several different
staphylococcal adhesins and corresponding receptors and is
not necessarily dependent upon the expression of single viru-
lence factors that are critical for the pathogenesis of S. aureus
infection at other sites.
Bacterial induction of epithelial IL-8 expression, while crit-
ical in the recruitment of a PMN response to bacterial infec-
tion in the airway (14), is not the only proinflammatory re-
sponse element expressed. To determine if there is a global
proinflammatory response to S. aureus, we also monitored the
expression of G-CSF and GM-CSF, which are NF-B-depen-
dent cytokines expressed by pulmonary epithelial cells in re-
sponse to bacteria (18). Whereas the ability to induce IL-8
expression was relatively conserved among the S. aureus
strains, the ability to stimulate GM-CSF production was sig-
nificantly diminished by loss of agr function. S. aureus mutants
lacking fibronectin binding proteins or lacking fibrinogen bind-
ing were unable to stimulate GM-CSF production, suggesting
a more specific ligand-receptor interaction in the GM-CSF
response. The fibrinogen binding domain of this adhesin has
been mapped (13), and it is possible that a similar locus is
available on respiratory cells. Alternatively, staphylococcal
“clumping,” a property conferred by clfA, may be necessary to
provide a sufficient bacterial stimulus to activate epithelial
signaling. Although expression of both IL-8 and GM-CSF is
regulated by NF-B, there is some specificity to the activation
of the epithelial response to staphylococcal gene products.
Staphylococcal peptidoglycan and lipoteichoic acid activate
NF-B-dependent gene expression through recognition of the
Toll-like receptors, specifically, TLR2 (35). However, the dis-
tribution and function of Toll-like receptors and associated
adapter proteins and signaling kinases have not been estab-
lished for airway epithelial cells. We were surprised to find that
lipoteichoic acid does not activate IL-8 expression, as we have
unpublished data that indicate that TLR-2 is available on the
cell lines used for these assays. Peptidoglycan, as expected, was
a potent stimulus for IL-8 expression and did not appear to be
affected by agr function. A more complete analysis of epithelial
Toll-like receptor function in mucosal cells is necessary for
identification of the additional components of the respiratory
epithelial signaling system.
Whereas the ability to elicit epithelial inflammatory re-
sponses was common to all of the S. aureus strains studied, only
organisms with intact agr and sarA loci caused severe invasive
infection in mice, with 100% rates of bacteremia and pneumo-
nia. Both loci are involved in the coordinate expression of
surface proteins and secreted exoproducts (5), their regulation
by bacterial growth phase (7), and expression of autoinducers
(16). The agr mutant caused bacteremia in fewer than half of
the animals inoculated and caused no mortality. The sarA
mutants, with minimal fibronectin binding protein A expres-
sion, as well as decreased hemolysin and toxin expression,
produced bacteremia in fewer than 20% of the mice. These
results are consistent with the known function of SarA in
activating the expression of S. aureus hemolysins that facilitate
local tissue destruction and entry into the bloodstream (5). The
expression of S. aureus fibronectin binding proteins is sufficient
for bacterial invasion in vitro (25). Fibronectin binding protein
A, which is increased in the agr mutant (33) and required for
internalization (9), may contribute to the 40% rate of bacte-
remia associated with infection due to agr mutant strain
RN6911. While it is difficult to ascribe the virulence phenotype
of a complex mutant to any single gene product, the pheno-
types observed can be explained by known effects of the agr and
sarA loci on major virulence factors. Interference with the
receptor histidine kinase of the highly conserved agr regulon
has been recently targeted as a potential inhibitor of S. aureus
virulence (19) and might be useful in this setting for the pre-
vention of invasive disease.
This distinction between the staphylococcal gene products
that initiate local inflammation in the airways and those asso-
ciated with invasive infection may be clinically relevant. An
analysis of S. aureus isolated from cystic fibrosis patients dem-
onstrated that many strains lack expression of agr-dependent
gene products in vivo (11). These cystic fibrosis patients have
significant airway inflammation but not invasive S. aureus in-
fection. The histology of these infections indicates that most
organisms are enmeshed in mucus and are neither adherent to
the epithelium nor intracellular (30). The experiments de-
scribed in this report may help to explain these clinical obser-
vations. Shed staphylococcal cell wall components, as well as
whole organisms, whether lysed or intact, contribute to the
activation of epithelial inflammatory responses. From our
studies, direct attachment of intact bacteria to epithelial re-
ceptors is not necessary for induction of epithelial cytokine
responses associated with PMN-dominated inflammation, al-
though it may be essential for initiation of invasive infection.
The pathogenesis of S. aureus infection of the airways, as
introduced by inhalation, has several important differences
from S. aureus infection of other sites. Although invasive in-
fection may require agr-mediated coordination of virulence
gene expression, the ability to stimulate PMN recruitment ap-
pears to be a widely conserved property of S. aureus. Strategies
for the inhibition or prevention of pulmonary S. aureus infec-
tion may require targets different from those expected to in-
terfere with the pathogenesis of other types of staphylococcal
infection.
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